The Urine Pregnancy Test: Everything you should know but probably don’t about the most common lab test
-
Register
- User - $30
The urine pregnancy test is the most common test performed in clinical care and yet we often do not treat it like other lab tests. When we perform a lab test, it is our clinical responsibility to interpret the test results, inform the patient, discuss treatment options and then either provide or refer for treatment. In the case of the pregnancy test, we often stop at informing the patient of the results. In this presentation, you will become comfortable interpreting pregnancy test results, discussing all treatment options and providing or referring for care. We will start with the basics of the pregnancy test: how long it takes for a pregnancy test to become positive after sex and menses; how long it takes to become negative after miscarriage and abortion and the expected trends of HCG levels in normal and ectopic pregnancies. You will learn how to provide the complete management of a negative pregnancy test including how to use it as an opportunity to prevent birth defects and intiate birth control using the quick start method. You will also gain all the skills you need to be comfortable providing the complete management of a positive pregnancy test. You will learn how to inform a patient of a positive pregnancy test in a non-judgemental and supportive manner. You will learn how to discuss all treatment options of a positive pregnancy test including abortion. We will talk about the landscape of abortion access in the U.S. and how to provide resources and referrals for abortion care.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.0 Contact Hours; 0.50 are Pharmacology
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 8/19/2025 to 8/20/2026 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: August 19, 2026
$30.00
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
-Understand pregnancy testing and HCG trends in early pregnancy
-Provide the complete management of a negative pregnancy test
-Provide the complete management of a positive pregnancy test
Rachael Phelps, MD
Dr. Rachael Phelps is a family planning expert who has provided contraceptive and abortion care at Planned Parenthood of Central and Western New York for 25 years, of which she served as Medical Director for 13 years. She co-led the Greater Rochester LARC Initiative and has worked in legally restrictive settings in Asia and Africa to decrease maternal mortality from unsafe abortion.
She received her medical degree from The Johns Hopkins School of Medicine. She completed a Pediatrics Residency and a Complex Family Planning Fellowship at the University of Rochester. She is currently a clinical instructor in the departments of Pediatrics and OB/GYN at the University of Rochester. She lectures nationally and internationally about the prevention of unintended pregnancy, evidence-based contraception and access to safe abortion care.
She received the Women Leaders in Medicine Award from The American Medical Student Association, the Hannah G. Solomon Humanitarian Award from the National Council of Jewish Women and was profiled in the New York Times Magazine article “The New Abortion Providers.”
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.0 contact hours, of which 0.50 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 8/20/2025 to 8/19/2026 .
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid from 8/20/2025 to 8/19/2026 . PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURES
Faculty
Contributing faculty, Rachael Phelps MD has disclosed:
Bayer Clinical trainer only. NO involvement w/ sales IUD Mirena/Kyleena/Skyla
Organon Clinical trainer for FDA required training program. No involvement w/sales Implant Nexplanon
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
Key:
Complete
Next
Failed
Available
Locked
